TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

UK Research and Innovation - Oligonucleotide Synthesis and Nucleic Acid Sequencing Services Framework

Peptones and protein substances
Research and development services and related consultancy services
UK
Published value
Not published
Submission deadline Not published
Lots published12
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: UK Research and Innovation: "UK Research and Innovation - Oligonucleotide Synthesis and Nucleic Acid Sequencing Services Framework". Published status: complete. Published value: Value not published. 12 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityUK Research and InnovationScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: UK Research and Innovation
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for UK Research and Innovation. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
17.2Bids / Report
0% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 12 active published awards; 12 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUK Research and Innovation
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published25 Jun 2024, 10:50 BST
Last source update25 Jun 2024, 10:50 BST
Recurring procurementNot published
ClassificationPeptones and protein substances, Research and development services and related consultancy services
Delivery area
UK
OCIDocds-h6vhtk-03f0a6
What is being bought
***This is an Award Notice, Not a Call for Competition**** This Framework has been established for the provision of UK Research and Innovation: Oligonucleotide Synthesis and Nucleic Acid Sequencing Services . This Framework is being Established for a term of 3 years + 1 year
What changed
From the official release history
  1. tender value changed
    25 Jun 2024, 10:50 BST
  2. Status changed to complete
    25 Jun 2024, 10:50 BST
  3. Official notice release published
    25 Jun 2024, 10:50 BST
  4. Submission deadline changed to published date
    25 Jun 2024, 10:50 BST
  5. Buyer information updated
    25 Jun 2024, 10:50 BST
  6. Status changed to active
    15 Sept 2023, 15:09 BST
  7. Official notice release published
    15 Sept 2023, 15:09 BST
  8. Submission deadline changed to 23 Oct 2023, 10:00 BST
    15 Sept 2023, 15:09 BST
  9. Buyer information updated
    15 Sept 2023, 15:09 BST
  10. Published value updated to £8,000,000
    17 Aug 2023, 13:13 BST
  11. Status changed to planned
    17 Aug 2023, 13:13 BST
  12. Official notice release published
    17 Aug 2023, 13:13 BST
  13. Buyer information updated
    17 Aug 2023, 13:13 BST
Lots and requirements (12)
Published by the contracting authority
  • Lot 1 · #Sub Lot 1.1
    Sub Lot 1.1
    cancelled
    Published valueNot published
    Sub lot 1.1 - First Generation Nucleic Acid sequencing services For the above sub lot, UKRI wish to put in place a framework for the purchase of a range of user selectable Nucleic Acid sequencing (Sanger/ ~800-1000 base pair read) services to be provided. This could include but is not limited to the following: • Provide Phred 20 quality for as many nucleotides per sample as possible (min 800 bp or above for 5' 3' reads). • Provide purification and sequencing of plasmids and PCR products in both 1.5 ml tubes and microtiter plates (must offer 96 well as a minimum). • Provide purification and sequencing of plasmids supplied as Escherichia coli clones in both 1.5 ml tubes and microtiter plates (must offer 96 well as a minimum). • Provide sequencing services using both primers synthesized by supplier and those with user provided primers. • Provide Primer walking services in both double and single stranded DNA.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #Sub Lot 1.2
    Sub Lot 1.2 - Second Generation Nucleic Acid Sequencing Services
    cancelled
    Published valueNot published
    Sub lot 1.2 - Second Generation Nucleic Acid sequencing services For the above sub lot, UKRI wish to put in place a framework for the purchase of a range of Second Generation sequencing services from a range of samples and formats including tubes, microtiter plates, preparation & extractions services including from colonies and tissue samples. A range of user selectable Nucleic Acid sequencing services are required that could include but not limited to: • Ligation or sequencing by synthesis • Pyrosequencing • Dye sequencing • Semiconductor based sequencing • Provide sample pick-up or sample mailing/courier service as required. • Provide purification and sequencing of samples supplied • Offer suitable solutions to templates failing to give readable results
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #Sub Lot 1.3
    Sub Lot 1.3 - Third Generation Nucleic Acid Sequencing Services
    cancelled
    Published valueNot published
    Sub lot 1.3 - Third Generation Nucleic Acid sequencing services For the above Sub Lot, UKRI wish to put in place a framework for the purchase of a range of Third generation sequencing services from a range of samples and formats including tubes, microtiter plates, preparation & extractions services including from colonies and tissue samples utilising novel or 'next generation technologies. A range of user selectable Nucleic Acid sequencing services are required that could include but not limited to: • PCR determination • combinatorial probe-anchor synthesis (cPAS) • fluorescently labelled antibody binding sequencing • Single-molecule real-time (SMRT) sequencing • zero-mode waveguide sequencing • sequencing of DNA via Nano pore transition
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #Sub Lot 2.1
    Sub Lot 2.1 - Custom Gene fragment synthesis (sub 2000bp)
    cancelled
    Published valueNot published
    Sub lot 2.1 - Custom Gene fragment synthesis (sub 2000bp) UKRI wish to put in place a framework for the purchase of a user selectable (via supplier engagement) range of Custom Gene Synthesis (sub 2000bp). For the above sub lot, a range of user selectable additional services should be available (but are not mandatory). This could include but is not limited to the following: • Genes produced with additional synthetic Nucleotides (AGTC + XY) • Custom vector production • Codon optimized sequences - all species • Site-directed mutagenesis • Bacterial, yeast, Baculovirus and mammalian gene expression services • Complex sequence synthesis - GC rich, AT rich, complex repeats & hairpin structures and toxic sequences
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #Sub Lot 2.2
    Sub Lot 2.2 - Custom Gene synthesis (2001 - 3000bp)
    cancelled
    Published valueNot published
    UKRI wish to put in place a framework for the purchase of a user selectable (via supplier engagement) range of Custom Gene Synthesis (2001 - 3000bp). For the above sub lot, a range of user selectable additional services should be available (but are not mandatory). This could include but is not limited to the following: • Genes produced with additional synthetic Nucleotides (AGTC + XY) • Custom vector production • Codon optimized sequences - all species • Site-directed mutagenesis • Bacterial, yeast, Baculovirus and mammalian gene expression services • Complex sequence synthesis - GC rich, AT rich, complex repeats & hairpin structures and toxic sequences
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 6 · #Sub Lot 2.3
    Sub Lot 2.3 - Custom Gene synthesis (3001-5000bp)
    cancelled
    Published valueNot published
    Sub Lot 2.3 - Custom Gene synthesis (3001-5000bp) UKRI wish to put in place a framework for the purchase of a user selectable (via supplier engagement) range of Custom Gene Synthesis (3001 - 5000bp). For the above sub lot, a range of user selectable additional services should be available (but are not mandatory). This could include but is not limited to the following: • Genes produced with additional synthetic Nucleotides (AGTC + XY) • Custom vector production • Codon optimized sequences - all species • Site-directed mutagenesis • Bacterial, yeast, Baculovirus and mammalian gene expression services • Complex sequence synthesis - GC rich, AT rich, complex repeats & hairpin structures and toxic sequences
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 7 · #Sub Lot 2.4
    Sub Lot 2.4 - Custom Gene synthesis (5001+ bp)
    cancelled
    Published valueNot published
    UKRI wish to put in place a framework for the purchase of a user selectable (via supplier engagement) range of Custom Gene Synthesis (5001 + bp). For the above sub lot, a range of user selectable additional services should be available (but are not mandatory). This could include but is not limited to the following: • Genes produced with additional synthetic Nucleotides (AGTC + XY) • Custom vector production • Codon optimized sequences - all species • Site-directed mutagenesis • Bacterial, yeast, Baculovirus and mammalian gene expression services • Complex sequence synthesis - GC rich, AT rich, complex repeats & hairpin structures and toxic sequences
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 8 · #Sub Lot 3.1
    Sub Lot 3.1 - Gene Specific DNA Methylation
    cancelled
    Published valueNot published
    Sub Lot 3.1 - Gene Specific DNA Methylation UKRI wish to put in place a Framework for the purchase of a range of Gene Specific DNA Methylation services are required to include, but not limited to: o Perform Bisulfite modification. o Perform PCR reactions. o Perform Pyrosequencing analysis.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 9 · #Sub Lot 3.2
    Sub Lot 3.2 - Global DNA Methylation
    cancelled
    Published valueNot published
    Sub Lot 3.2 - Global DNA Methylation UKRI wish to put in place a Framework for the purchase of a range of global DNA methylation services are required to include, but not limited to: o LC MS DNA-methylation analysis. o ELISA that enables the direct quantitation of genomic DNA methylation. o PCR based methods e.g.; Alu and LINE1. o Methylation sensitive restriction assays e.g.; luminometric methylation assay (LUMA).
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 10 · #Sub Lot 3.3
    Sub Lot 3.3 - Allele Quantification
    cancelled
    Published valueNot published
    Sub Lot 3.3 - Allele quantification UKRI wish to put in place a Framework for the purchase of a range of Allele quantification services are required to include, but not limited to: o SNP detection and quantification. o Assay development for SNP detection and quantification from pooled DNA with a defined 100bp target region in murine DNA. o Validation of the above assay. o Sample testing if required for the above assay.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 11 · #Sub Lot 4.1
    Sub Lot 4.1 - Synthesis of DNA Oligonucleotides
    cancelled
    Published valueNot published
    Sub Lot 4.1 - Synthesis of DNA oligonucleotides. UKRI wish to put in place a framework for the purchase of a range of custom Oligonucleotide synthesis services including Custom DNA oligo's in tubes, plates and RNA/siRNA, to be user selectable via supplier engagement with a range of purification and modification options. The production of custom user defined oligonucleotides in the following ranges are required (Inc. plates). • 0.01UM bases standard • 0.05UM bases standard • 0.2UM bases standard • 1.0UM bases standard • 0.025 UM / 3OD • Microtiter plates
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 12 · #Sub Lot 4.2
    Sub Lot 4.2 - Synthesis of Custom RNA Oligo's (both Single and double stranded RNA oligoes, siRNA) the supply of siRNA Libraries and the production of custom SiRNA Libraries
    cancelled
    Published valueNot published
    Sub Lot 4.2 - Synthesis of Custom RNA oligo's (both Single and double stranded RNA oligoes, siRNA) the supply of siRNA Libraries and the production of custom SiRNA Libraries UKRI wish to put in place a framework for the purchase of a range of custom Oligonucleotide synthesis services including Custom DNA oligo's in tubes, plates and RNA/siRNA, to be user selectable via supplier engagement with a range of purification and modification options. The production of custom user defined oligonucleotides in the following ranges are required (Inc. plates). • 0.01UM bases standard • 0.05UM bases standard • 0.2UM bases standard • 1.0UM bases standard • 0.025 UM / 3OD • Microtiter plates
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    25 Jun 2024, 10:50 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  15. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  16. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  17. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  18. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  19. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  20. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  21. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  22. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  23. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  24. Contract active
    Signed 1 May 2024, 00:00 BST · £0
  25. Contract active
    Signed 1 May 2024, 00:00 BST · £0
Commercial outcome and competition
Awards
CeGat GmbH
Not published · Not published · active
LIFE TECHNOLOGIES LIMITED
Not published · Not published · active
SOURCE BIOSCIENCE UK LIMITED
Not published · Not published · active
IDT DNA
Not published · Not published · active
EDINBURGH GENETICS LIMITED
Not published · Not published · active
Eurofins Genomics UK Ltd
Not published · Not published · active
Eurogentec Ltd
Not published · Not published · active
GENEWIZ UK LIMITED
Not published · Not published · active
Macrogen Europe
Not published · Not published · active
MERCK LIFE SCIENCE UK LIMITED
Not published · Not published · active
Randox Laboratories Ltd
Not published · Not published · active
Twist Bioscience
Not published · Not published · active
Contracts
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Contract
£0 · signed 1 May 2024, 00:00 BST · active
Bid statistics
bids: 10
bids: 14
bids: 15
bids: 29
bids: 14
bids: 29
bids: 8
bids: 35
bids: 10
bids: 31
electronicBids: 31
electronicBids: 10
electronicBids: 14
electronicBids: 15
electronicBids: 29
electronicBids: 14
electronicBids: 29
electronicBids: 8
electronicBids: 35
electronicBids: 10
bids: 6 (lot Sub Lot 1.1)
electronicBids: 6 (lot Sub Lot 1.1)
bids: 5 (lot Sub Lot 1.3)
electronicBids: 5 (lot Sub Lot 1.3)
Buyer and organisations in this procedure

UK Research and Innovation

Contracting authority GB-FTS-90451
View buyer profile
  • UK Research and Innovation
    buyer

    Polaris House,North Star Avenue, SWINDON, UKK14, SN21UH
    +44 1793867005
  • CeGat GmbH
    supplier

    HRB729958
    Paul-Ehrlich-Straße 23, Tuebingen, Germany, DE, D-72076
  • Edingburgh Genetics Limited
    supplier

    GB-COH: SC650426
    Pentlands Science Park, Penicuick, UKM, EH26 0PZ
  • Eurofins Genomics UK Ltd
    supplier

    GB-COH: 03297407
    i54 Business Park, Valiant Way, Wolverhampton, UK, WV9 5GB
  • Eurogentec Ltd
    supplier

    GB-COH: (SC)139668
    The Square Fawley, Southampton, Hampshire, UK, SO45 1DD
  • Genewiz UK Ltd
    supplier

    GB-COH: 09937828
    Bullocks Lane, Hope End, Takeley, Essex, UK, CM22 6TA
  • IDT DNA
    supplier

    GB-COH: 9869050
    London City Point, 1 Ropemaker Street, London, UK, EC2Y 9HT
  • Life Technologies Limited
    supplier

    GB-COH: SC083107
    3 Fountain Drive, Inchinnan Business Park, Paisley, UK, PA4 9RF
  • Macrogen Europe
    supplier

    NL04618247
    Meibergdreef 57, 1105 BA, Amsterdam, The Netherlands, NL
  • Merck Life Science UK Limited
    supplier

    GB-COH: 00660457
    The Old Brickyard, New Road, Gillingham, Dorset, UK, SP8 4XT
  • Randox Laboratories Ltd
    supplier

    GB-COH: NI015738
    55 The Diamond Road, Crumlin, Co Antrim, UK, BT29 4QY
  • Source Bioscience UK Ltd
    supplier

    GB-COH: 04078501
    1 Orchard Place, Nottingham Business, Nottinghamshire, UK, NG8 6PX
  • Twist Bioscience
    supplier

    333-231239
    681 Gateway Blvd, South San Francisco, CA 94080, US
  • UK Shared Business Services Ltd
    reviewBody

    Polaris House, North Star Avenue, Swindon, SN2 1FF
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published